Cross Country Healthcare falls on report about FTC review of Aya deal
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 06 2025
0mins
Should l Buy CCRN?
Source: SeekingAlpha
FTC Review Impact: Cross Country Healthcare's stock fell 6.2% following reports of the FTC's review revealing "troubling documents" regarding its $615 million sale to Aya Healthcare, with no further details disclosed.
Deal Status: Despite receiving a second request from the FTC, Cross Country expects the acquisition deal to close in the latter half of the year after shareholder approval was granted last month.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CCRN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CCRN
Wall Street analysts forecast CCRN stock price to fall
8 Analyst Rating
1 Buy
7 Hold
0 Sell
Hold
Current: 9.860
Low
8.65
Averages
9.66
High
11.00
Current: 9.860
Low
8.65
Averages
9.66
High
11.00
About CCRN
Cross Country Healthcare, Inc. is a technology-enabled workforce solution and advisory company. The Company’s segments include Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs; education healthcare services; in-home care services, and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, government facilities and managed care organizations.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Leadership Appointment: Cross Country Healthcare has appointed Chris Tyrell as Chief Information Officer to drive enterprise technology investment and execution, particularly in AI and automation, supporting the expansion of its Intellify® platform.
- Extensive Industry Experience: With over 20 years of technology leadership experience, Tyrell previously served as Chief Technology Officer at Eclipse Advantage, where he led enterprise platform strategy and system transformations, which is expected to enhance Cross Country's technical execution.
- Strategic Investment Focus: Tyrell emphasizes that technology must do more than support the business; it must drive growth, as Cross Country continues to invest in predictive workforce intelligence and workflow automation to improve outcomes for clients and internal teams.
- Vision for Future Development: CEO Kevin Clark states that Tyrell's addition will help the company maintain a competitive edge in technology, strengthen the enterprise architecture, scale Intellify, and execute the next phase of its AI and technology roadmap.
See More
- Earnings Call Schedule: Cross Country Healthcare will hold its earnings call on May 7, 2026, at 5:00 PM ET to discuss Q1 2026 financial results, reflecting the company's commitment to transparency and investor communication.
- Earnings Release Timing: The company plans to release its earnings after market close, ensuring that investors have access to the latest financial information prior to the call, thereby enhancing the timeliness and accuracy of market reactions.
- Live Webcast and Replay: The call will be webcast live on the company's website, with dial-in options available, and a replay will be accessible from May 7 to May 21, increasing information accessibility and investor engagement.
- Tech-Driven Workforce Solutions: Cross Country Healthcare leverages its Intellify® platform to provide AI-powered workforce management solutions that help healthcare organizations optimize resources, reduce costs, and improve service quality, showcasing the company's technological leadership in the healthcare sector.
See More
- Community Partnership: Cross Country Healthcare has announced a new partnership with South Florida nonprofit Open Hearts for Orphans, aimed at supporting orphaned and vulnerable children through community engagement and employee involvement, reflecting a shared mission to improve family and community outcomes.
- Mission-Driven Collaboration: This partnership emphasizes the importance of supporting vulnerable children and strengthens the commitment of both organizations to provide care and hope, with a goal of creating measurable impact for children and families through strategic initiatives.
- Employee Engagement Opportunities: Cross Country Healthcare will promote long-term collaboration with OHFO through employee engagement opportunities and awareness-building activities, further enhancing community support to ensure that orphaned and vulnerable children receive the necessary care and stability.
- Tech-Driven Solutions: Cross Country Healthcare leverages its AI-powered digital platform and advisory services to optimize healthcare workforce ecosystems, ensuring that while supporting vulnerable children, the overall quality and efficiency of care are also improved.
See More
- Earnings Miss: Cross Country Healthcare reported a Q4 non-GAAP EPS of -$0.06, missing expectations by $0.09, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Decline: The company’s Q4 revenue of $236.8M represents a 23.6% year-over-year decline, falling short by $17.5M, reflecting weak market demand and intensified competition, which may hinder future growth prospects.
- Future Guidance: Management's guidance for Q1 2026 revenue is set at $235M to $240M, projecting a year-over-year decline of 20% to 18%, indicating a lack of confidence in short-term recovery, which could affect shareholder investment decisions.
- Adjusted EBITDA Outlook: The expected adjusted EBITDA range of $4.0M to $5.0M reflects a year-over-year decline of 54% to 42%, highlighting significant challenges in cost control and operational efficiency that may impact the company’s competitive position in the market.
See More
- Earnings Announcement Date: Cross Country Healthcare (CCRN) is set to release its Q4 2023 earnings on March 4th after market close, with consensus EPS estimate at $0.03, reflecting a 25% year-over-year decline, and revenue expected at $254.3 million, down 17.9% year-over-year, indicating significant challenges ahead for the company.
- Historical Performance Review: Over the past two years, CCRN has beaten EPS estimates 50% of the time and revenue estimates 63% of the time, suggesting a degree of capability to exceed expectations, yet the recent downward revisions may undermine investor confidence.
- Expectation Revision Trends: In the last three months, EPS estimates have seen one upward revision and three downward revisions, while revenue estimates have experienced no upward revisions and four downward revisions, reflecting a cautious market outlook that could lead to stock price volatility.
- Merger Termination Impact: CCRN recently terminated its merger with Aya Holdings, which will incur a $20 million fee, and while this decision may negatively impact stock prices in the short term, it also provides the company with greater flexibility for future independent growth.
See More






